Skip to content
Entourage
News1 min read

New Regulatory Update Briefing on MDR and IVDR

The European Commission has put forward significant changes to MDR and IVDR. Our new Regulatory Update Briefing makes sense of the current proposals, from product delineation to integrated products.

EE

Entourage Editorial Team

What it covers

On 16 December 2025 the European Commission presented its proposal to develop the MDR and IVDR further (COM(2025) 1023 final, procedure 2025/0404(COD)). The proposed changes go beyond formalities and concern, among other things, the delineation between medical devices and in-vitro diagnostics and the treatment of integrated products.

Three focus areas in the briefing

  • The new delineation mechanism between medical devices and IVDs
  • Integrated products and the question of the "principal action"
  • Accessories for Annex XVI products under the MDR

Access

Our regulatory experts track the proposals continuously and translate their practical consequences. The briefings are gathered in the Regulatory Update Hub and accessible after free registration. The Commission's reform proposal for the MDR and IVDR is analyzed in depth in MDR/IVDR under reconstruction.

Image notice: The images in this article were generated using artificial intelligence. They do not depict real people, places, or events.

Relevant for your project?

Similar questions in your current project?

In a first call we clarify what is specifically relevant for your situation, without obligation.

Request a call →

Life Science Journal

Regulatory updates, straight to your inbox.

New requirements, authority decisions and practice notes. Once a month, unsubscribe any time.

Regulations & standards considered

  • EU 2017/745 (MDR)
  • EU 2017/746 (IVDR)

Related expertise

MDR Conformity →

Support through classification, technical documentation and conformity assessment.

IVD Consulting & IVDR Readiness →

Interpreting and implementing IVDR requirements along the product classes.

Related projects

All case studies →
Case Study

Design Transfer of Combination Products from Development to Production

A medical device company with combination products needed to make the design transfer from development to production more efficient while overcoming regulatory hurdles under the EU MDR and the FDA.

Case Study

Global Market Access After the IVDR Transition: 100 Percent On-Time TGA Submissions

Following the transition to the IVDR, a diagnostics manufacturer had to meet pressing compliance deadlines set by the Australian Therapeutic Goods Administration, with limited internal capacity and diverging requirements across multiple international markets.

Sources
  • Entourage, company announcement on theentourage.de (29 Jan 2026)
  • European Commission, proposal COM(2025) 1023 final of 16 Dec 2025, procedure 2025/0404(COD)

Related insights

All insights →
Article
Article

Regulatory due diligence: the deadlines and registers against which a data room is measured (MDR Art. 120, IVDR Art. 110, EUDAMED, Art. 16 and 10a)

A data room shows what the target company produces. Whether that is enough is decided by the legal text: MDR Art. 120 ties continued sales under an MDD certificate to May 26, 2024 and September 26, 2024, IVDR Art. 110 sets staggered dates up to 2027, EUDAMED has been mandatory in four modules since May 28, 2026, and Art. 16 MDR turns a buyer who sells the device under its own name after closing into the manufacturer with all obligations. There are also three public registers: EudraGMDP, the EUDAMED module "Notified Bodies & Certificates" and the FDA Warning Letter database. What a regulatory due diligence has to establish per device, with references.

Read more →

Article
Article

eIFU since July 2025: permitted for all devices intended for professional users

Implementing Regulation (EU) 2025/1234 removed the device list from the eIFU Regulation: since July 16, 2025, any medical device intended for professional users may be supplied with instructions for use in electronic form instead of on paper. The risk assessment, the seven-day deadline for paper copies and the lay-person rule remain, the review provision for notified bodies has been deleted, and the eIFU web address belongs in the UDI database.

Read more →

MDR/IVDR under reconstruction: how Europe is recalibrating its medical device framework
Article

MDR/IVDR under reconstruction: how Europe is recalibrating its medical device framework

From the accelerated evaluation and COM(2025) 1023 to market feedback, parliamentary work and Council negotiations: how the MDR/IVDR revision is really unfolding, and what it means for ongoing projects.

Read more →

Your project

Have a concrete project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? +49 89 4161170-0
info@theentourage.de

  • Reply usually within one working day
  • 4 offices: DE · CH · IT · US
  • 100% life sciences